HPV vaccine expanding to boys from September could prevent over 100,000 cancers


Facebook
Twitter
LinkedIn

By Eleanor Philpotts

09 Jul 2019

Public Health England (PHE) has officially launched the universal HPV vaccine programme to include boys.

From September, 12-13-year-old schoolboys will be eligible to receive the vaccine, which protects against the Human Papilloma Virus. The expansion of the free service, introduced for girls in 2008, has led to estimates that the vaccination programme will prevent over 64,000 cervical cancers and nearly 50,000 non-cervical cancers by 2058.

Head of immunisation at HPE, Dr Mary Ramsay said: ‘This universal programme offers us the opportunity to make HPV-related diseases a thing of the past and build on the success of the girls’ programme.

‘It’s important not to delay vaccination, as the vaccine may be less effective as adolescents get older.’

HPV incorporates over 100 viruses, and as well as cervical cancer, can be linked to conditions affecting the skin, moist membranes, head and neck, including other forms of cancer.

Currently, ten million doses of the HPV vaccine have been given to young women in the UK, resulting in over 80% of women aged 15-24 having received it. Since its introduction, infections of some types of HPV (HPV 16/18) in 16-21-year-old women have reduced by 86% in England, while a Scottish study showed that the vaccine has reduced pre-cancerous cervical disease in women by up to 71%. Similarly, diagnoses of genital warts have declined by 90% in 15-17-year-old girls and 70% in 15-17-year-old boys.

Last year, the BMA put forward a case to a House of Commons debate for HPV vaccination for boys. It was then announced last July that boys would receive the vaccination in the future, following advice by the Joint Committee on Vaccination and Immunisation. The Welsh Government also declared this the same month, with the news expanding to Northern Ireland earlier this year.

BMA board of science chair Professor Dame Parveen Kumar said: ‘The BMA has for a long time been calling for an extension of the HPV vaccination programme to be extended to boys in UK and the confirmation that this will go ahead in September is very welcome as it will undoubtedly reduce the risk of young men contracting cancers linked to the virus in adult life.

‘Universal HPV vaccination is the most effective way of preventing HPV-related infection and disease. Given the growing body of evidence that HPV is also responsible for a range of cancers that can affect men, this is a very important step.

‘Following the success of the vaccination programme for girls, it is only right that boys are now afforded the same protection.’

National cancer director at NHS England Cally Palmer commented: ‘By extending the HPV vaccine to boys, the NHS is taking an important step forward in our fight to prevent cancer – more people will be better protected, and the vaccine could help to eliminate cervical cancer in this country.

‘Cancer survival is now at an all-time high, and the NHS long term plan will save even more lives through enhanced screening and early diagnosis programmes to catch cancers sooner when they can be treated best.’

Public health minister Seema Kennedy added: ‘Programmes like this are at the heart of our work to help people live longer, healthier lives through the NHS long term plan and I would encourage everyone who is eligible to take up this potentially life-saving vaccine.’

 


Want news like this straight to your inbox?


Latest News

Vaping still safer than smoking, health officials reiterate amidst fresh concerns
Public health officials have reiterated that regulated e-cigarettes carry a 'fraction' of the risk of...
Cost of medicines prescribed in primary care falls by almost £250m since last year, figures reveal
The cost of medicines in England prescribed in primary care has fallen by almost £250m...
Community pharmacies and GP practices can share flu vaccine stock without wholesaler licence
Community pharmacies and GP practices will no longer be barred from sharing flu vaccination stock...